Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Mattioli Woods plc
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 08 05 2024] - (CGWL)
-
Form 8.3 - Nightcap plc
-
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
-
Midaxo Honored as Gold Stevie® Award Winner in 2024 American Business Awards®
-
StepStone Group to Announce Fourth Quarter and Fiscal 2024 Results on May 23, 2024
-
Pharmacist-led clinics improve access to health care: Lessons from Alberta
-
Noom Adds Muscle Defense™ to Its GLP-1 Companion Program to Help Prevent Muscle-Mass Loss While Taking GLP-1s
-
JumpCloud Delivers Powerful New Features for Google Workspace and Google Cloud Customers
-
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
-
Sportradar to Participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 21
-
Abcourt confirms a second gold mineralized zone East of the Flordin deposit toward the Cartwright sector in the Lebel-sur-Quévillon area
-
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
-
PEEK WEALTH is proud to announce the newest addition to its financial team, Brett Elliott, formally of Edward Jones
-
ORYZON to Provide Corporate Progress Updates at Several Events in May
-
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
-
Dental Influencers Alliance Attendees Praise Halo Dental Technologies’ Digital Mirror at Annual Get Together
-
SPAR Group, Inc. Announces Timing of First Quarter Results Conference Call
-
Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation
-
Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
-
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
-
Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer Conference
-
Zscaler to Host Third Quarter Fiscal Year 2024 Earnings Conference Call
-
Westland Express launches API integration to streamline tenant insurance for property managers
-
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
-
Perma-Fix Reports Financial Results and Provides Business Update for the First Quarter of 2024
-
Cerevance Presents at IAPRD XXIX World Congress on Parkinson’s Disease and Related Disorders
-
AEON Biopharma Provides Update on Development Pipeline
-
Stryker declares a $0.80 per share quarterly dividend
-
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
-
Meet-up in 798: the Global Art Destination Captivates 300,000 visitors with Cultural Extravaganza During May Day Holiday
-
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
-
Terra CO2 Enters Permitting Stage for High-Performance Cement Extender Plant in Texas, Creating a Near-Term Solution for Increased Production and Carbon Reduction
-
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
-
ACELYRIN, INC. Announces Leadership Transition
-
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
-
Fulcrum Therapeutics to Participate in Upcoming May Conferences
-
Xunlei Limited Schedules 2024 Unaudited First Quarter Earnings Release on May 16, 2024
-
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
-
CareCloud Retains Citizens JMP as its Exclusive Capital Structure Advisor
-
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea
-
Annexon Biosciences to Present at the Bank of America Health Care Conference
-
Treasure Global’s ZCITY Secures US$2Million Marketing Contract through its AI Marketing Engine
-
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Stryker declares a $0.80 per share quarterly dividend
-
Direct Travel Continues Growth Momentum with New Additions to Executive Team
-
Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
-
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
-
Motiv Completes Delivery of Additional 55 Electric Trucks to Purolator
